The role of vascular smooth muscle cell apoptosis and migration during uterine spiral artery remodeling in normal human pregnancy
Loading...
Date
Authors
Bulmer, Judith
Innes, Barbara
Levey, Joanne
Robson, Stephen
Lash, Gendie
Journal Title
Journal ISSN
Volume Title
Publisher
Federation of American Societies for Experimental Biology
Abstract
During human uterine spiral artery
(SpA) remodeling, vascular smooth muscle cells
(VSMCs) are lost and replaced by fibrinoid, incorporating extravillous trophoblast (EVT) cells. The aim of the
current study was to determine the relative contributions of apoptosis and migration to VSMC loss during
SpA remodeling. Immunohistochemistry (Apoptag, active caspase 3, lamin) of placental bed biopsies (8 –20
wk gestation) demonstrated apoptotic cells in all samples; double immunolabeling identified these as trophoblasts, leukocytes, and endothelial cells. In total,
294 SpAs were studied, and only one apoptotic VSMC
was identified. H-caldesmon-immunopositive VSMCs
were observed surrounding and separate from SpA
walls in partially remodeled vessels; the highest level of
VSMC migration was observed in vessels with associated EVT cells (number of migrated cells 6.4 1.2;
distance migrated 3.5 0.3 pixels) compared with those
without (number of migrated cells 3.6 0.5, P<0.001;
distance migrated 2.8 0.1 pixels, P<0.0001). VEGF-A,
VEGF-C, TGF-1, and Ang-2 all stimulated human
aorta VSMC invasion in vitro, although EVT cell culture
supernatants did not. In summary, apoptosis is unlikely
to play a major role in loss of VSMCs from SpAs during
remodeling in normal pregnancy, but VSMCs appear
to migrate away from the wall of the SpA, an effect
enhanced by the presence of EVT cells.—Bulmer,
J. N., Innes, B. A., Levey, J., Robson, S. C., Lash,
G. E. The role of vascular smooth muscle cell
apoptosis and migration during uterine spiral artery
remodeling in normal human pregnancy. FASEB J. 26,
2975–2985 (2012). www.fasebj.org
Description
Keywords
Citation
Collections
Source
FASEB Journal
Type
Book Title
Entity type
Access Statement
License Rights
Restricted until
2099-12-31